Co Diagnostics earnings were -$36.0M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest CODX earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$7.7M, up 2.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CODX reported annual earnings of -$37.6M, with 6.5% growth. The next CODX earnings date is Nov 6, 2025.
On CODX's earnings call on Invalid Date, Co Diagnostics (NASDAQ: CODX) reported Q2 2025 earnings per share (EPS) of -$0.23, up 8% year over year. Total CODX earnings for the quarter were -$7.73 million. In the same quarter last year, Co Diagnostics's earnings per share (EPS) was -$0.25.
The next CODX earnings date is Invalid Date. Add CODX to your watchlist to be reminded of Co Diagnostics's next earnings date.
Is Co Diagnostics profitable or losing money?
As of the last Co Diagnostics earnings report, Co Diagnostics is currently losing money. Co Diagnostics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$35.99 million, a 4.2% decrease year over year.
What was CODX's earnings growth in the past year?
As of Co Diagnostics's earnings date in Invalid Date, Co Diagnostics's earnings has grown year over year. CODX earnings in the past year totalled -$35.99 million.
What are Co Diagnostics's earnings expectations?
The current EPS estimate for Co Diagnostics's earnings report in Invalid Date is -$0.12.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.